Prostate Cancer - Results from #26120

The clinical merit of anti-RANKL antibody denosumab in prostate cancer - Abstract April 3, 2012

Early clinical data show galeterone safe, effective against prostate cancer April 2, 2012

Metformin appeared to slow prostate cancer growth April 2, 2012

Oral vitamin D supplements reduced levels of Ki67 in prostate cancer cells April 2, 2012

Lack of oxygen influenced tumor behavior and patient outcome in intermediate-risk prostate cancer April 2, 2012

Novel technology allows for noninvasive imaging of prostate cancer April 2, 2012

Weill Cornell investigators among several centers chosen for "dream team" awarded $10 million to study metastatic prostate cancer April 2, 2012

Prostate Cancer: Prevalence - Incidence - Mortality April 2, 2012

EAU Guidelines on Prostate Cancer April 2, 2012

Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy - Abstract April 2, 2012

Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study - Abstract April 2, 2012

Imaging diagnosis for prostate cancer biochemical recurrence after radical treatment - Abstract April 2, 2012

Treatment of the patient with castration-resistant biochemical progression of prostate cancer - Abstract April 2, 2012

Prostate Cancer Etiology April 2, 2012

Prostate Cancer Prognostic Nomograms April 2, 2012

A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 Update - Abstract April 2, 2012

Prostate bed motion during intensity-modulated radiotherapy treatment - Abstract April 2, 2012

Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: A population-based study - Abstract April 2, 2012

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer - Abstract April 2, 2012

Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate - Abstract April 2, 2012

Page 1307 of 1437